They reported that NRF2 activity was gradually higher in grades II to IV, whereas no constitutive NRF2 activity was detected in grade I. NRF2 expression may therefore be a useful biomarker to predict WHO grade and cellular behaviour of brain tumours [315]. Here, NFE2L2 is linked to brain neoplasm.